These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34951653)

  • 21. Familial combined hypolipidemia: angiopoietin-like protein-3 deficiency.
    Arca M; D'Erasmo L; Minicocci I
    Curr Opin Lipidol; 2020 Apr; 31(2):41-48. PubMed ID: 32022755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatty acids and hypoxia stimulate the expression and secretion of the adipokine ANGPTL4 (angiopoietin-like protein 4/ fasting-induced adipose factor) by human adipocytes.
    González-Muniesa P; de Oliveira C; Pérez de Heredia F; Thompson MP; Trayhurn P
    J Nutrigenet Nutrigenomics; 2011; 4(3):146-53. PubMed ID: 21709421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity.
    Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Konrad RJ
    Heliyon; 2021 Sep; 7(9):e07898. PubMed ID: 34504977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity.
    Kovrov O; Kristensen KK; Larsson E; Ploug M; Olivecrona G
    J Lipid Res; 2019 Apr; 60(4):783-793. PubMed ID: 30686789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4.
    Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Roell WC; Konrad RJ
    Biochem Biophys Res Commun; 2021 Jan; 534():498-503. PubMed ID: 33239171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of angiopoietin-like 4 and lipoprotein lipase in human adipose tissue.
    Dijk W; Schutte S; Aarts EO; Janssen IMC; Afman L; Kersten S
    J Clin Lipidol; 2018; 12(3):773-783. PubMed ID: 29555209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 7-day high-PUFA diet reduces angiopoietin-like protein 3 and 8 responses and postprandial triglyceride levels in healthy females but not males: a randomized control trial.
    Kaviani S; Taylor CM; Stevenson JL; Cooper JA; Paton CM
    BMC Nutr; 2019; 5():1. PubMed ID: 32153916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk.
    Kersten S
    Curr Opin Lipidol; 2019 Jun; 30(3):205-211. PubMed ID: 30893111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum progranulin concentrations are not responsive during oral lipid tolerance test and oral glucose tolerance test.
    Schmid A; Leszczak S; Ober I; Schäffler A; Karrasch T
    Horm Metab Res; 2015 Jul; 47(8):571-6. PubMed ID: 25565096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-Term Regulation of Lipocalin-2 but not RBP-4 During Oral Lipid Tolerance Test and Oral Glucose Tolerance Test.
    Schmid A; Leszczak S; Ober I; Schäffler A; Karrasch T
    Horm Metab Res; 2016 Feb; 48(2):99-105. PubMed ID: 26069091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes.
    Shimamura M; Matsuda M; Kobayashi S; Ando Y; Ono M; Koishi R; Furukawa H; Makishima M; Shimomura I
    Biochem Biophys Res Commun; 2003 Feb; 301(2):604-9. PubMed ID: 12565906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum angiopoietin-like 3 levels are elevated in obese non diabetic men but are unaffected during an oral glucose tolerance test.
    Garcés MF; Buell-Acosta JD; Rodríguez-Navarro HA; Pulido-Sánchez E; Rincon-Ramírez JJ; Moreno-Ordóñez DC; Franco-Vega R; Roncancio-Muñoz JS; Burgos-Cardenas AJ; Lacunza E; Castaño JP; Diéguez C; Nogueiras R; Sanchez E; Caminos JE
    Sci Rep; 2020 Dec; 10(1):21118. PubMed ID: 33273510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice.
    Fowler A; Sampson M; Remaley AT; Chackerian B
    Vaccine; 2021 Sep; 39(40):5780-5786. PubMed ID: 34474934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical angiopoietin-like protein that regulates ANGPTL3.
    Quagliarini F; Wang Y; Kozlitina J; Grishin NV; Hyde R; Boerwinkle E; Valenzuela DM; Murphy AJ; Cohen JC; Hobbs HH
    Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19751-6. PubMed ID: 23150577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota.
    Janssen AWF; Katiraei S; Bartosinska B; Eberhard D; Willems van Dijk K; Kersten S
    Diabetologia; 2018 Jun; 61(6):1447-1458. PubMed ID: 29502266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiopoietin-like proteins inhibitors: New horizons in the treatment of atherogenic dyslipidemia and familial hypercholesterolemia.
    Surma S; Romańczyk M; Filipiak KJ
    Cardiol J; 2023; 30(1):131-142. PubMed ID: 33470417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced miR-181d level in obesity and its role in lipid metabolism via regulation of ANGPTL3.
    Abu-Farha M; Cherian P; Al-Khairi I; Nizam R; Alkandari A; Arefanian H; Tuomilehto J; Al-Mulla F; Abubaker J
    Sci Rep; 2019 Aug; 9(1):11866. PubMed ID: 31413305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia.
    Ruscica M; Zimetti F; Adorni MP; Sirtori CR; Lupo MG; Ferri N
    Pharmacol Res; 2020 Mar; 153():104653. PubMed ID: 31931117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of angiopoietin-like protein 3 and 4 reveals structural and mechanistic similarities.
    Gunn KH; Gutgsell AR; Xu Y; Johnson CV; Liu J; Neher SB
    J Biol Chem; 2021; 296():100312. PubMed ID: 33482195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.
    Köster A; Chao YB; Mosior M; Ford A; Gonzalez-DeWhitt PA; Hale JE; Li D; Qiu Y; Fraser CC; Yang DD; Heuer JG; Jaskunas SR; Eacho P
    Endocrinology; 2005 Nov; 146(11):4943-50. PubMed ID: 16081640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.